Updated: January 25, 2026
What Is Imuran? Uses, Dosage, and What You Need to Know in 2026
Author
Peter Daggett

Summarize with AI
Imuran (azathioprine) is an immunosuppressant used for kidney transplant rejection and autoimmune conditions. Here's everything patients need to know in 2026.
Imuran is the brand name for azathioprine, a prescription immunosuppressant that has been used in medicine since the 1960s. Despite being an older medication, it remains a cornerstone therapy for preventing organ transplant rejection and managing a wide range of autoimmune conditions. Here is everything you need to know about Imuran in 2026.
What Is Imuran (Azathioprine)?
Imuran (azathioprine) is an immunosuppressant in the class of medications called purine antimetabolites and disease-modifying antirheumatic drugs (DMARDs). It works by reducing the activity of the immune system — specifically by preventing T and B lymphocytes (white blood cells) from multiplying. This makes it useful both for preventing the immune system from rejecting a transplanted organ and for calming the overactive immune responses that drive autoimmune diseases.
The FDA first approved azathioprine in March 1968, making it one of the earliest immunosuppressants in clinical use. It is available as a generic under the name azathioprine (multiple manufacturers), as brand-name Imuran (50 mg tablets), and as Azasan (75 mg and 100 mg tablets).
FDA-Approved Uses for Imuran
The FDA has approved Imuran for two specific indications:
Kidney transplant rejection prevention: Imuran is used as an adjunct therapy — alongside corticosteroids and calcineurin inhibitors — to prevent the immune system from rejecting a newly transplanted kidney.
Active rheumatoid arthritis (RA): Imuran is indicated for RA to reduce signs and symptoms, typically used as a second-line DMARD after methotrexate failure or intolerance.
Common Off-Label Uses
While only approved for the two conditions above, azathioprine is widely used off-label for many other conditions, including:
Crohn's disease and ulcerative colitis (IBD) — as a steroid-sparing maintenance agent
Systemic lupus erythematosus (lupus nephritis)
Myasthenia gravis (as a steroid-sparing agent)
Autoimmune hepatitis (maintenance therapy alongside steroids)
Multiple sclerosis, neuromyelitis optica
Severe psoriasis, atopic dermatitis, pemphigus, bullous pemphigoid
Vasculitis, Behcet's disease, dermatomyositis, recurrent pericarditis
Dosage: How Much Imuran Will You Take?
Dosing varies significantly by indication and body weight:
Kidney transplant (initial): 3–5 mg/kg/day starting at the time of transplant; typically reduced to a maintenance dose of 1–3 mg/kg/day
Rheumatoid arthritis (initial): 1 mg/kg/day (typically 50–100 mg); may increase by 0.5 mg/kg every 4 weeks up to a maximum of 2.5 mg/kg/day
Doses for off-label uses vary. The most common tablet strength is 50 mg, taken once or twice daily depending on your total daily dose. Imuran should generally be taken with food to reduce nausea.
How Long Does It Take Imuran to Work?
Imuran is a slow-acting medication. For rheumatoid arthritis, it typically takes 6–8 weeks to see initial response and up to 12 weeks to experience the full benefit. If there is no improvement after 12 weeks at the maximum tolerated dose, your doctor may consider the medication ineffective and discuss alternatives. This slow onset is one reason azathioprine should never be stopped abruptly — it needs to be taken consistently over time to maintain its effect.
Is Imuran a Controlled Substance?
No. Imuran (azathioprine) is not a controlled substance and is not scheduled by the DEA. It requires a standard prescription and cannot be refilled without a new prescription in states with annual prescription limits, but there are no special DEA-imposed restrictions on prescribing, dispensing, or possession.
For a deeper explanation of how azathioprine works at the molecular level, see our article How Does Imuran Work? If you're struggling to find Imuran at your pharmacy, medfinder can help you locate a pharmacy near you that has it in stock.
Frequently Asked Questions
Imuran (azathioprine) is FDA-approved for preventing kidney transplant rejection and for treating active rheumatoid arthritis. It is also widely used off-label for inflammatory bowel disease (Crohn's disease, ulcerative colitis), lupus, myasthenia gravis, autoimmune hepatitis, multiple sclerosis, and various inflammatory skin conditions.
Imuran is a brand name for azathioprine. Generic azathioprine contains the same active ingredient at the same dose and is therapeutically equivalent to brand Imuran. Generic versions are significantly less expensive. Azasan is another brand name available in 75 mg and 100 mg tablet strengths.
For rheumatoid arthritis, it typically takes 6 to 8 weeks to see the first signs of improvement, and up to 12 weeks to experience the full benefit. Imuran is considered a slow-acting drug. For transplant patients, the medication's effect on preventing rejection is ongoing as long as it's taken.
Many patients take azathioprine safely for years with regular monitoring. Long-term risks include an increased risk of lymphoma, skin cancer, and infections due to chronic immune suppression. Your doctor will monitor you with regular blood counts, liver tests, and skin cancer screening. The lowest effective dose is always recommended for long-term therapy.
Yes, and it's recommended. Taking Imuran with food or immediately after a meal significantly reduces the risk of nausea and stomach upset, which are the most common side effects. Splitting the daily dose into two smaller doses taken with meals (morning and evening) also helps with GI tolerability.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Imuran also looked for:
More about Imuran
34,519 have already found their meds with Medfinder.
Start your search today.





